Article and Video CATEGORIES

Cancer Journey

Search By

Ceritinib and Other Second Generation ALK Inhibitors for Acquired Resistance in ALK-Positive NSCLC
Author
GRACE Videos and Articles

Camidge_Ceritinib_Second_Generation_ALK_Inhibitors_Acquired_Resistance_ALK-Positive_NSCLC

 

Dr. Ross Camidge, University of Colorado, describes the second generation ALK-inhibitors which provide good options for ALK-positive NSCLC patients who have developed acquired resistance to crizotinib.

 

 

Transcript

One of the exciting things about the ALK field is that in a relatively short space of time, we’ve gone from defining a molecular subtype of lung cancer that responds very nicely to a first generation drug, crizotinib, that we’ve actually not got more choices. More specific, more potent ALK inhibitors have been developed: ceritinib, alectinib, brigatinib to name a few. Ceritinib is already licensed — the other two drugs have got what’s called FDA breakthrough approval. That means the FDA is very keep to look at the results, and hopefully if they’re good, will license the drug fairly quickly.

What they’re showing is, one: because they tend to be slightly cleaner drugs, they have a different side effect profile from crizotinib. For example they tend to not have the swelling of the ankles and other areas of swelling which is associated with an off target effect of crizotinib called anti-MET activity. However they’re not completely free from side effects. Ceritinib for example has a lot of gastrointestinal side effects — a lot of nausea, a lot of vomiting and diarrhea, and nearly 60% of people need a dose reduction. The alectinib and brigatinib are looking relatively cleaner in terms of the side effects.

In terms of whether they work: after the crizotinib has stopped working, people have progressed in one of two ways. Either their cancer is growing in their brain because crizotinib doesn’t penetrate into the brain very well, or the cancer has evolved and changed its biology in the presence of the crizotinib.

The good news is these next generation drugs work on both of those mechanisms. Either more is getting into the brain or the drug is just more potent, and therefore we’re seeing responses in the brain, and also they work on some of the known resistance mechanisms to crizotinib. We’re seeing 50-70% of people responding in their body after initially progressing on crizotinib.

So very rapidly we now have a clearly defined next line of therapy for ALK-positive patients progressing on crizotinib.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Patient Education Ambassadors 2023-24
Video
Drs. Matthew Kurian, Karan Jatwani, and Karine Tawagi discuss risk factors for developing prostate cancer, PSA test in prostate cancer screening, biopsies in prostate cancer, among other relevant information about prostate cancer. To watch the full playlist click here.  
Image
Patient Education Ambassadors 2023-24
Video
La Dra. Ivy Riano analiza las diversas opciones de tratamiento para pacientes con cáncer y analiza las diversas opciones de tratamiento para pacientes con cáncer. Para ver la lista completa de videos da click aquí.

Forum Discussions

Hi ramosking,  Welcome to Grace.  I'm sorry you're suffering.  It doesn't sound like you have a pancoast tumor. It does seem like you should see your PCP or a pulmonologist for...

Hey, So I went to the Doctor and explained all my symptoms I was having, They did some examining by listening to my lungs with a stethoscope, They said my lungs...

I hope you find some help through your doc or PT. 

Take care,

Janine

Hi Revtoby, Welcome to Grace.  I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...

Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...

Recent Comments

JOIN THE CONVERSATION
I hope you find some help…
By JanineT GRACE … on
Went to doctor
By ramosking on
Hi ramosking,  Welcome to…
By JanineT GRACE … on
Hi Mackensie,  I'm sorry…
By JanineT GRACE … on